RPL22 blocking peptide product blog
Tags: Blocking Peptide; RPL22 ; RPL22 blocking peptide;
The RPL22 rpl22 (Catalog #MBS9228675) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The RPL22 rpl22 product has the following accession number(s) (GI #4506613) (NCBI Accession #NP_000974.1) (Uniprot Accession #P35268). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Anemia, Carcinoma, Cell Transformation, Neoplastic, Inflammation, Liver Neoplasms, Lung Diseases, Lung Neoplasms, Necrosis, Neoplasm Metastasis, Precancerous Conditions are some of the diseases may be linked to RPL22 Blocking Peptide(C-term). Blood, Bone, Brain, Liver, Lung, Lymph, Lymph Node, Skin, Spleen, Stomach tissues are correlated with this protein. RPL22 also interacts with the following gene(s): RPL11, RPL14, RPL15, RPL24, RPL30, RPL4, RPL5. The following patways have been known to be associated with this gene.